Serum autoantibodies profiling and early-stage cancer detection;Autoanticorps et diagnostic prècoce des cancers

Medecine/Sciences

Volumn 27, Issue 6-7, 2011, Pages 633-638

  Desmetz, Caroline ^a,b,c   Lacombe, Jérôme ^a,b,c   Mange, Alain ^a,b,c   Maudelonde, Thierry ^a,b,c   Solassol, Jérôme ^a,b,c  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b CENTRE VAL D AURELLE   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CANCER ANTIBODY; RECOMBINANT PROTEIN; TUMOR MARKER;

BLOOD; BREAST TUMOR; DNA SEQUENCE; EARLY DIAGNOSIS; FEMALE; FORECASTING; HUMAN; IMMUNOLOGY; INTRADUCTAL CARCINOMA; LUNG TUMOR; MAMMOGRAPHY; MASS SCREENING; MASS SPECTROMETRY; METHODOLOGY; MOLECULAR CLONING; NEOPLASM; PATHOLOGY; PROTEOMICS; RADIOGRAPHY; REPRODUCIBILITY; REVIEW; RISK; SPECTROFLUOROMETRY;

ANTIBODIES, NEOPLASM; AUTOANTIBODIES; AUTOANTIGENS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CLONING, MOLECULAR; EARLY DIAGNOSIS; FEMALE; FORECASTING; HUMANS; LUNG NEOPLASMS; MAMMOGRAPHY; MASS SCREENING; MASS SPECTROMETRY; NEOPLASMS; PROTEOMICS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; RISK; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, FLUORESCENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 79960938508     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2011276016     Document Type: Article

References (30)

1. Etzioni R, Urban N, Ramsey S, et al. The case for early detection, tot Rev Cancer 2003;3:243-52. (Pubitemid 37328860)
2. Kulasingam V, Diamandis HP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Not Clin Pract Oncol 2008;5:588-99.
3. Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as biomarkers for early cancer detection. Febs J 2009;276:6880-904.
4. Soussi T. p53 Antibodies in the sera of potients with various types of cancer: a review Cancer Res 2000;60:1777-88. (Pubitemid 30207629)
5. Schubert U, Antón LC, Gibbs J, et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000;404:770-4. (Pubitemid 30212405)
6. Chen YT, Scanlan MJ, Sahm U, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997;94:1914-8. (Pubitemid 27113936)
7. Ulanet DB, Torbenson M, Dang CV, et al. Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci U S A 2003;100:12361-6. (Pubitemid 37271565)
8. von Mensdorff-Pouitly S, Petrakou E, Kenemans P, et al. Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides. Int J Cancer 2000;86:702-12. (Pubitemid 30249883)
9. Wandall HH, Blixt O, Tarp MA, et al. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes Cancer Res 2010;70:1306-13.
10. Hansen MK, Nielsen H, Ditzel HJ. The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells. Proc Natl Acad Sci USA 2001;98:12659-64. (Pubitemid 33020002)
11. Hanash S. Harnessing immunity for cancer marker discovery. Nat Btotechnot 2003;21:37-8. (Pubitemid 36055824)
12. Anderson KS, LaBaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res 2005;4:1123-33. (Pubitemid 41208670)
13. Li Y, Karjalamen A, Koskinen H, et al. p53 autoantibodies predict subsequent development of cancer. Int J Cancer 2005;114:157-160. (Pubitemid 40194322)
14. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71. (Pubitemid 44631359)
15. Madoz-Gúrpide J, Kuick R, Wang H, Misek DE, Hanash SM. Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Mol Cell Proteomics 2008;7:268-81. (Pubitemid 351298441)
16. Chen G, Wang X, Yu J, Varambally S, et al. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res 2007;67:3461-7. (Pubitemid 46724887)
17. Chapman CJ, Murray A, McElveen JE, et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008;63:228-33. (Pubitemid 351373718)
18. Boyle P, Chapman CJ, Holdenrieder S, et al. Clinical validation of an autoantibody test for lung cancer. Ann Oncol 2011;22:383-9.
19. Leidinger P, Keller A, Ludwig N, et al. Toward an early diagnosis of lung cancer: an autoantibody signature far squamous cell lung carcinoma Int J Cancer 2008;123:1631-6
20. Leidinger P, Keller A, Heisel S, et al. Identification of lung cancer with high sensitivity and specificity by blood testing. Respir Res 2010;11:18.
21. Launoy G. Epidemiology of cancers in France. Rev Prat 2010;60:178-82.
22. Desmetz C, Bascoul-Mollevi C, Rochaix P, et al. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. Clin Cancer Res 2009;15:4733-41.
23. Chapman C, Murray A, Chakrabarti J, et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 2007;18:868-73. (Pubitemid 47054083)
24. Wang X, Yu J, Sreekumar A, Varambally S, et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005;353:1224-35. (Pubitemid 41345944)
25. Caron M, Choquet-Kastylevsky G, Joubert-Caron R. Cancer immunomics using autoantibody signatures for biomarker discovery. Mot Cell Proteorntcs 2007;6:1115-22. (Pubitemid 47099223)
26. Sahin U, Tureci O, Pfreundschuh M. Serological identification of human tumor antigens Curr Opm Immunol 199;9:709-16.
27. Flahault A, Costaghola D. Is lung cancer screening by the helical scanner justified ? Med Sci (Paris) 2007;23:333-4. (Pubitemid 46472678)
28. Hill C. Critical interpretation of the cancer incidence increase in France. Med Sci (Pans) 2009;25:297-9.
29. Desmetz C, Mangé A, Solassol J. Comparison of proteomic strategies to identify antibodies resulting from the humoral immune response to cancer. Med Sci (Paris) 2008;24:1071-6.
30. Julian-Reynier C. Prédisposition génétique aux cancers du sein et de I'ovaire: importance des résultats des tests. Med Sci (Paris) 2011;27:657-61.